Legal Representation
Attorney
Brian Chau
USPTO Deadlines
Next Deadline
20 days remaining
Published for Opposition
Due Date
January 08, 2026
Extension Available
Until February 08, 2026
Application History
14 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 9, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 9, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 3, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 7, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 20, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 20, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 20, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 24, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 24, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 24, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 23, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 9, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 18, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 18, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemical agents for scientific research use, namely, macromolecules for the purpose of scientific research about supporting the viability and function of therapeutic transplants including medical device and cell therapy transplants, for use in the scientific research about discovery of new methods regarding implantable medical devices and cell therapies
Class 005
Pharmaceutical preparations for the treatment of endocrine diseases and oncological diseases; stem cells for medical purposes; stem cells and progenitor cells for medical purposes, specifically, for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system; stem cells and progenitor cells for medical purposes, specifically, for use in the production of biologic substances, namely, growth factors and proteins; Hormone replacement therapy preparations; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for use in immunomodulation therapies; surgical implants comprised of living tissues; surgical implants comprising living tissue, namely, surgical implants grown from stem cells; Chemical agents for medical use, namely, macromolecules for the purpose of supporting the viability and function of therapeutic transplants including medical device and cell therapy transplants, for use in the development of implantable medical devices and cell therapies; chemical agents for medical purposes, namely, the coating of implantable medical devices and for encapsulating pharmaceutical agents and cells for the purpose of supporting the viability and function of therapeutic transplants including medical device and cell therapy transplants
Class 010
Implants consisting of artificial materials for medical use and diagnostic use; coatings sold as an integral component of implantable medical devices, namely, coatings comprised of polymers and chemical compounds
Class 042
Research and development of immune system treatments; Medical and scientific research in the field of stem cell therapy and cell transplantation therapies; Medical research; biopharmaceutical development, research and product evaluation of stem cell-based therapeutics for the treatment of diseases and disorders; Laboratory services for the production of therapeutical cellular products and the active ingredients for cell based therapies
Class 044
Medical treatment using cultured cells; stem cell therapy services
Classification
International Classes
001
005
010
042
044